KROS · Keros Therapeutics, Inc.
$10.14
-0.07 (-0.69%)
At close · Jul 23
Market Cap
$200.69M
Shares
19.79M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 611 | $10.93 | $6,678 |
| 2026-06-25 | 2 | $10.92 | $22 |
| 2026-06-22 | 68 | $10.65 | $724 |
| 2026-06-18 | 97 | $10.41 | $1,010 |
| 2026-06-17 | 576 | $10.03 | $5,777 |
| 2026-06-16 | 5 | $10.24 | $51 |
| 2026-05-28 | 149 | $11.31 | $1,685 |
| 2026-05-06 | 643 | $11.77 | $7,568 |
| 2026-05-04 | 240 | $11.49 | $2,758 |
| 2026-05-01 | 155 | $11.12 | $1,724 |
Showing 1–10 of 10 settlements
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
18 filings
17 filers
Visit website
Investor relations